Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Top Home Luxury Scent of 2024

In this article, we will talk about the Top Home Luxury Scent of 2024. For our detailed discussion, go directly to the Top 25 Home Luxury Scents of 2024

The high-end perfume industry was valued at $13.66 billion in 2022 and is predicted to grow to $19.62 billion by 2029, with a 5.3% CAGR between 2023 and 2029, as mentioned in our article, “11 Best Travel-Size Fragrances For Your Next Vacation.” As previously stated in our article “15 Best Everyday Colognes in 2024,” the global perfume market stood at $50.85 billion in 2022 and is anticipated to increase at a CAGR of 5.9% between 2023 and 2030.

Inter Parfums, Inc. (NASDAQ:IPAR)’s Financial Performance Over The Years; Should You Buy This Stock? 

Inter Parfums, Inc. has been a global fragrance company since 1982, producing and distributing luxury fragrances and associated items through license agreements with brand owners. The company operates in two segments: European activities through its 72% owned subsidiary, Interparfums SA, and United States operations through fully owned subsidiaries in the US and Italy. Prestigious brands such as Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Donna Karan/DKNY, Emilio Pucci, Ferragamo, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, MCM, Moncler, Montblanc, Oscar de la Renta, Roberto Cavalli, and Van Cleef & Arpels are distributed globally through a diverse network of distributors in over 120 countries.

The fragrance company reports that net sales for the year ended March 31, 2024, increased 4% to $324 million from $312 million at the same time the previous year, and earnings per share were $1.27, down 24% from the same quarter last year, despite missing Zacks consensus estimates of $331 million and $0.34, respectively.

The company’s operational income had a sharp decline of 24.7% from the previous year, mostly due to a very high comparable margin in Q1/2023. The slower growth is expected to be set aside in 2024, according to Inter Parfums’ confirmed forecast. The business anticipates $1.45 billion in sales, a 10.0% rise over 2023. The adjusted EPS is predicted to increase by 8.4% to $5.15; although Q1 was not great overall, the challenges appear to be rapidly improving and returning to solid growth.

IPAR’s stock has declined more than 18% over the previous year and has dipped over 21% in the current year as of June 18th, 2024, although it has outperformed the S&P 500’s 15% gain over the same period, suggesting investors might be bullish on this stock but have a high risk at the same time due to a significant decline of 21%. In addition, the stock has risen over 64% in the previous five years, indicating a growth in share price. That’s a positive sign for investors. It also illustrates IPAR’s growth as a business. The trailing PE ratio stands at 25.80, while the forward PE ratio is 21.74. EPS (TTM) is $4.34. Currently, the stock is trading at $111.23 per share.

Revenues increased by only 3.9% year on year, down from 21.3% in 2023, as Inter Parfums’ clients destocked inventory in the quarter, according to the report. Yet, the success of the US-based operations contributed to a rise in revenues. If we look at the bigger picture, the company has made its position stronger in the perfume market due to a constant increase in revenue year over year.

As we have mentioned above, the rise in sales and annual revenue is due to North America, the company’s largest market, demonstrating resilience despite a 3% dip in comparable quarter sales. This reduction is mostly due to the concentration of new releases in the early months of 2023. Western Europe’s sales increased by 10%, but Eastern Europe’s sales fell by 22% owing to supply delays in certain areas, forcing revenues to shift to the second quarter.

Asia-Pacific witnessed a 13% revenue increase, boosted by excellent results in Australia and India. Significant growth was also observed in Central and South America, where sales increased by 31% in the first quarter. However, sales in the Middle East and Africa fell by 5%, owing to economic and social disruptions caused by continuing hostilities in those regions, as well as phased product launches.

On the bright side, the company introduced several new perfumes in the first quarter of 2024, including additions to the long-running lines for Oscar de la Renta and Anna Sui. The Donna Karan Cashmere Collection, Rochas Orange Horizon, Kate Spade Bloom, Van Cleef & Arpels Encens Précieux, Karl Lagerfeld Rouge, Montblanc Legend Blue, and Lacoste L12.12 Blanc and L12.12 Rose all made their debuts in the first quarter. IPAR’s first-ever sales of existing Lacoste and Roberto Cavalli scents reaffirm its belief in these two new fragrance lines. Among its top brands, GUESS saw the biggest sales rise of 21% throughout the quarter. GUESS is IPAR’s fourth-largest brand. All signs for the brand are positive and suggest another great year, especially with a very strong innovation schedule for the rest of the year, as the company stated in its latest earnings report. To support company development throughout the year and make up for fewer new product releases than the previous year, IPAR raised advertising and promotional expenditures in the first quarter of this year. The business reveals that investing more this quarter and much more in the fourth quarter of 2023 is working in its favor because it enables it to drive sell-out ahead of sell-in. In addition, IPAR is continuing to create interesting content and execute omnichannel concepts with known scent lovers to broaden its reach and visibility in significant ways.

Looking forward, Mr Madar stated:

“We increased advertising and promotional investments in the first quarter to fuel business growth throughout the year and to compensate for lighter new product launches than in the prior year. Our decision to spend significantly more during the fourth quarter of 2023, combined with higher spending this quarter, is proving to be a winning strategy as it enables us to drive sell-out ahead of sell-in. Additionally, we are continuing to develop compelling content and implement omnichannel concepts with renowned fragrance enthusiasts to further expand our reach and exposure in meaningful ways.” Mr. Madar concluded, “The fragrance market is resilient, and we are determined to continue to gain market share by implementing our strategies effectively. We believe the favorable market conditions and prevailing tailwinds will far outweigh any challenges we may encounter.”

Meanwhile, investors are also piling money into this company. Consistent with the previous quarter’s 22 funds, 22 hedge funds reported owning shares in Inter Parfums, Inc. (NASDAQ:IPAR) in Q1 FY 2024. The company’s largest shareholder, Chuck Royce’s Royce & Associates, owns 489,283 shares valued at $68,75 million.

Headwaters Capital Management echoed this sentiment in its fourth quarter 2023 investor letter, emphasizing the appeal of Inter Parfums, Inc. (NASDAQ:IPAR):

Buys: Inter Parfums, Inc. (NASDAQ:IPAR): Inter Parfums is a leading fragrance house that partners with prestige brands to develop, manufacture, market and distribute perfumes globally under licensing agreements. IPAR was founded in 1982 by Jean Madar and Phillipe Benacin, who collectively own 44% of the company. Both founders are still actively involved in the company with Mr. Madar serving as the CEO of IPAR’s US operations while Mr. Benacin is CEO of the European business, Inter Parfums SA (publicly traded European subsidiary that is 72% owned by IPAR). IPAR focuses on licensing agreements with prestige brands that already have a devoted brand following in categories outside of fragrances. IPAR typically targets brands with fragrances that have either been under-managed or are relatively nascent but have large growth potential via a dedicated fragrance strategy. IPAR’s top fragrance brands include Montblanc, Jimmy Choo, Coach, and Guess. Over the last 2 years, IPAR has added fragrance licenses with Ferragamo, DKNY, Lacoste and Roberto Cavalli, all of which should meaningfully contribute to revenue growth for the company going forward.

The fragrance market is a niche category that requires scale and expertise that is better outsourced to a third party than managed internally by leading brands. The cost to design, market and distribute a fragrance line is too expensive relative to the potential revenue from the product. While top fragrance brands can generate revenue of $1-2 billion, most successful fragrance brands generate revenue in the $10-200mm range. Despite the small size, category extension into fragrances can still be a lucrative business for brands and serves to enhance the value of the brand if managed correctly. As a result, prestige brands often enter into licensing agreements with dedicated fragrance houses such as IPAR to manage their fragrance category. IPAR leverages their internal expertise that is required to design, manufacture, market and distribute a single fragrance over many brands…” (Click here to read the full text)

Conclusion: 

The growth narrative of Inter Parfums is still gaining strength even after a weak first quarter. The fact that IPAR’s US-based activities are successful suggests that its market is robust. Interparfums has expanded effectively since the business was able to get a rich portfolio of licenses. I believe IPAR will continue to expand as a result of new product releases and developments. TipRanks reports that 3 Wall Street analysts with a consensus “Strong Buy” recommendation have offered IPAR 12-month price goals during the past three months. According to these experts, IPAR has an upside potential of more than 45% based on its average price target of $161.50.

While we acknowledge the potential of IPAR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an Al stock that is as promising as IPAR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. 

With that said, here is the Top Home Luxury Scent of 2024.  

Methodology:

To pick out the Top Home Luxury Scent of 2024, we searched the internet for the top luxury home scents and ranked them based on their number of appearances in our sources, so each appearance got one score. Then we ranked the list based on the aggregated scores. We have also included each scent’s price and quantity in our list, using the price as a tie-breaker in case two or more scents had the same score. The prices that we have mentioned are for particular products with varying capacities, mostly relying on Sephora and Nordstrom for the data. Please note, however, that we can’t guarantee the accuracy of these prices, since they can vary from region to region.

At Insider Monkey, we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

1.  Le Labo Santal 33 

Insider Monkey Score: 12

Price: $322 for 3.4 o.z  

The top home luxury scent of 2024 is Santal 33, a woody aromatic scent offered by Le Labo, a high-end fragrance brand. Le Labo’s Santal 33 combines cardamom notes with notes of violet and iris. The scent comes from the addition of spicy, leathery, and musky elements to the smoking wood alloy, composed of Australian sandalwood and cedarwood.

Click to see the entire list of the Top 25 Home Luxury Scents of 2024

If you are looking for an AI stock that is as promising as Microsoft but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and Jim Cramer is Recommending These 10 Stocks in June.

Disclosure: None.Top 25 Home Luxury Scents of 2024 is originally published on Insider Monkey. We focus on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…